Breast Cancer Flashcards

(34 cards)

1
Q

How common is breast cancer

A

Most common cancer in U.K.

Women have 1/8 lifetime risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Risk factors for breast cancer

A
Increasing age 
Previous history
Family history
HRT
Early menarche
Late menopause
Low parity
Obesity
High alcohol consumption
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Differential for nipple discharge

A
Duct ectasia
DCIS
Papilloma
Infection/abscess
Physiological
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Differential for areolar change

A

Eczema

Paget’s disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Differential for breast lump

A

Cancer
Cyst
Fibroadenoma
Fibrocystic change

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Differential for breast redness

A

Mastitis
Abscess
Cancer - peau d’orange

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the triple assessment of breast referrals

A

Clinical examination
Imaging - USS or mammogram
Pathology - biopsy histology or fine needle aspiration cytology

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Views of a mammogram

A

Caudio-cranial

Oblique

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What determines which form of imaging used

A

<40 use USS
>40 use mammogram
MRI for investigating breast implants, for high risk patient screening and to exclude multifocal disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Benefits of core biopsy histology

A

Can determine receptor status (ER and HER-2)

Can determine grade

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What USS features suggest benign disease

A

Well circumscribed

Hyper-echoic shadow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What features of mammography suggest malignant disease

A

Lots of microcalcification

Irregular

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What proportion of breast cancers are ER+

A

2/3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What proportion of breast cancers are HER-2+

A

1/3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What proportion of breast cancers are ER+ and HER-2+

A

20%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What proportion of breast cancers are not receptor positive

17
Q

Stepwise treatment for breast cancer

A
  1. Neoadjuvant chemo
  2. Surgery
  3. Chemo and/or radiotherapy (if both, chemo first)
  4. Biological and/or hormonal treatment
18
Q

What is the chemotherapy for breast cancer

A

FEC +/- taxanes

19
Q

What is the biological treatment and how long do you take it for

A

Herceptin for 1 year

20
Q

What is the hormonal treatment and how long do you take it for

A

Oestrogen antagonists e.g tamoxifen
Aromatase antagonists e.g anastrozole
5-10 years

21
Q

Surgical options for breast cancer

A

Mastectomy
Wide local excision
Sentinel lymph node biopsy
Axillary clearance

22
Q

When is a mastectomy preferred over WLE

A

Multifocal disease
Locally advanced: invading muscle/fascia, >5cm diameter (limit smaller for smaller breasts), skin ulceration
Patient choice
BRCA mutation

23
Q

Describe SLNB

A

Sentinel node is the first draining lymph node of the tumour found by injecting a dye or radioisotope

24
Q

Examples of breast reconstruction surgery

A

Implants only
Lat dorsi flap
Plastics - TRAM and DIEP

25
Side effects of breast/chest wall radiotherapy
Acute: skin reaction, pain Chronic: fibrosis, atrophy, telangiectasia
26
Disadvantages of oestrogen antagonists
Increased DVT risk Increased endometrial cancer risk Increased stroke/MI risk
27
Disadvantages of aromatase inhibitors
Increased osteoporosis risk Reduced oestrogen production in post menopausal women Can only be used in post menopausal women
28
How to calculate prognosis
Nottingham prognostic index: (Cancer size in mm x 0.2) + grade + node stage Gives a number which can be converted to a 10 year survival rate prediction
29
What determines prognosis
Better prognosis with: Lower NPI (smaller tumour, lower grade, lower node stage) Younger age
30
Median survival with metastatic breast cancer
18-24 months
31
Lifetime risk of breast and ovarian cancer with BRCA 1/2 mutation
BRCA1: 75% breast cancer, 50% ovarian cancer BRCA2: 50% breast cancer, 30% ovarian cancer
32
Why do you need to determine lobular or ductal
Lobular requires MRI before surgery because need accurate sizing, more likely to be multifocal and more likely to be bilateral
33
When can you do an oncogene assay
ER positive HER2 negative Intermediate prognostic score
34
Outcome of oncogene assay test
Gives score of 0-100 of risk of recurrence >35 need adjuvant chemo <25 adjuvant chemo has no benefit